Purple Majesty potato chips
OtherPurple Majesty potato chips
NCT Number: NCT02927015
Assess impact of potato phytochemical on post-prandial gastric emptying and glucose release from products in a pilot human study.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Preclinical data obtained using an Caco-2 intestinal cell model and enzyme assays suggest phenolic-rich potato extracts decrease intestinal glucose transport. The aim is to determine if these effects extend to the the an in vivo situation. Specifically, the glycemic response following consumption of phenolic rich pigmented potatoes compared to white potatoes with lower phenolic content will be measured. Gastric emptying will also be measured to show the effects are in fact due to rate of carbohydrate digestion and intestinal glucose transport and not gastric emptying rate.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Purple Majesty potato chips
Mountain Rose potato chips
White potato chips
Crackers
Time frame: up to 2 hours
blood taken at 10, 20, 30, 60, and 120 minutes by finger prick
Time frame: up to 4 hours
Breath Hydrogen concentrations will be measured every 15 minutes for 4 hours
Purdue University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07243743
Glycemic Response
Toronto, Ontario, Canada
View Trial DetailsNCT07175740
Behavior, Diabetes Mellitus
Québec, Quebec, Canada
View Trial DetailsNCT06797349
Glycemic Response
Toronto, Ontario, Canada
View Trial DetailsNCT06048978
Glycemic Response
Toronto, Ontario, Canada
View Trial Details